Consone AI a disruptive technology platform targeting decisions that are made in the drug development process.
ConsoneAI has raised $256K in total funding. The most recent round was Seed. The last funding was announced in March 2024.
ConsoneAI's investors include SFC Capital.
ConsoneAI is headquartered in London, United Kingdom.
Consone AI a disruptive technology platform targeting decisions that are made in the drug development process.
ConsoneAI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ConsoneAI — Funding & Investors." VCBacked, March 20, 2024, https://www.vcbacked.co/company/consoneai. Accessed August 14, 2026.
VCBacked. (2024). ConsoneAI — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/consoneai
{{cite web |title=ConsoneAI — Funding & Investors |url=https://www.vcbacked.co/company/consoneai |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated